Clinical Trials
22 trialsA Study of Tumor-Treating Fields (TTFields) in People With Lung Adenocarcinoma
Memorial Sloan Kettering Cancer Center
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
MOv19-BBz CAR T Cells in FRa+ Cancers
University of Pennsylvania
CAR T Cells in Mesothelin Expressing Cancers
University of Pennsylvania
Reinforced and Non-Reinforced Staple Lines in Fissureless Lobectomy
Surrey Thoracic Surgery Group
Photodynamic Therapy Using HPPH in Treating Patients With Stage 0 Non-Small Cell Lung Cancer
Roswell Park Cancer Institute
Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas
Memorial Sloan Kettering Cancer Center
Radiation Therapy and Ammonium Tetrathiomolybdate in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Roswell Park Cancer Institute
Romidepsin and Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
University of Texas Southwestern Medical Center
Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer
Barbara Ann Karmanos Cancer Institute
Specialized Radiation Therapy in Treating Patients With Stage II, Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer and Poor Performance Status
University of Texas Southwestern Medical Center
HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer
University of Washington
Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer
Medical University of South Carolina
Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer
University of Washington
Gefitinib, Docetaxel, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
Wake Forest University Health Sciences
Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer And Lung Dysfunction
Alliance for Clinical Trials in Oncology
Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Lung Adenocarcinoma Harboring Wild-type EGFR
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC
Virginia Commonwealth University
Photodynamic Therapy in Treating Patients With Lung Cancer
Roswell Park Cancer Institute
Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer
Memorial Sloan Kettering Cancer Center
Gene Therapy in Treating Patients With Cancer
Roger Williams Medical Center
Photodynamic Therapy With HPPH in Treating Patients With Non-Small Cell Lung Cancer
Roswell Park Cancer Institute